O. H. Krämer

The HDAC inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. (2003)

Krämer, O.H., Zhu, P., Ostendorff, H.P., Golebiewski, M., Tiefenbach, J., Peters, M.A., ...

Keystone Meeting 'Enzymology of Chromatine and Transcription', Santa Fe, N.M., March 10-13, 2003

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. (2003)

Krämer, O.H., Zhu, P., Ostendorff, H.P., Golebiewski, M., Tiefenbach, J., Peters, M.A., ...

The EMBO Journal, 22(2003) S.3411-20

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. (2002)

Göttlicher, M., Minucci, S., Zhu, P., Krämer, O.H., Schimpf, A., Giavara, S., ...

The EMBO Journal, 20(2001) S.6969-78

The teratogen valproic acid is a selective inhibitor of a subset of histone deacetylases. (2002)

Zhu, P., Krämer, O.H., Heinzel, T., Göttlicher, M.

43.Frühjahrstagung der Deutschen Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie (DGPT), Mainz, 12.-14.März 2002

The teratogen valproic acid defines a novel class of histone deacetylase inhibitors inducing differentiation of embryonic, transformed and tumorigenic cells. (2002)

Göttlicher, M., Minucci, S., Zhu, P., Krämer, O.H., Schimpf, A., Giavara, S., ...

43.Frühjahrstagung der Deutschen Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie (DGPT), Mainz, 12.-14.März 2002

Valproic acid defines a novel class of histone deacetylase inhibitors inducing differentiation of transformed and tumorigenic cells. (2002)

Göttlicher, M., Minucci, S., Zhu, P., Krämer, O.H., Schimpf, A., Giavara, S., ...

93rd Annual Meeting of the American Association for Cancer Research, San Francisco, Calif., April 6-10, 2002

Histone deacetylase as a therapeutic target. (2001)

Krämer, O.H., Göttlicher, M., Heinzel, T.

Trends in Endocrinology and Metabolism, 12(2001) S.294-300